Koki Shimizu

Also affiliated with Nagoya Memorial Hospital, Faculty of Public Health, Shinshu University Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review”.

Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review

Japanese Journal of Clinical Oncology(2020)10.1093/jjco/hyaa125

N/A

0DataRank · unranked

11 citations

Hiroyuki Kawashima, Akira Kawai, Masahiro Yoshida, Yoshihiro Nishida, Koki Shimizu

Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review

Japanese Journal of Clinical Oncology(2020)10.1093/jjco/hyaa080

N/A

0DataRank · unranked

9 citations

Shunsuke Hamada, Hiroshi Koike, Koki Shimizu, Masahiro Yoshida, Yoshihiro Nishida +1 more

Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review

Japanese Journal of Clinical Oncology(2020)10.1093/jjco/hyaa078

N/A

0DataRank · unranked

2 citations

Shunsuke Hamada, Tomohisa Sakai, Koki Shimizu, Masahiro Yoshida, Yoshihiro Nishida +1 more